Sector
PharmaceuticalsOpen
₹19.19Prev. Close
₹19.5Turnover(Lac.)
₹1.67Day's High
₹19.75Day's Low
₹18.952 Week's High
₹40.1852 Week's Low
₹17.61Book Value
₹9.63Face Value
₹10Mkt Cap (₹ Cr.)
33.35P/E
62.68EPS
0.31Divi. Yield
03 Oct 2024
12:00 AM
AGM
Announcement Date: 03 Oct, 2024
21 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 16.31 | 15.5 | 15.5 | 15.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.46 | -2.02 | -2.84 | 1.31 |
Net Worth | 14.85 | 13.48 | 12.66 | 16.81 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 14.53 | 26.42 | 20.09 | 13.98 |
yoy growth (%) | -44.98 | 31.48 | 43.72 | 14.03 |
Raw materials | -11.75 | -23.52 | -18.34 | -12.46 |
As % of sales | 80.87 | 89.02 | 91.3 | 89.15 |
Employee costs | -0.41 | -0.46 | -0.34 | -0.36 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.19 | 0.18 | 0.24 | 0.18 |
Depreciation | -0.22 | -0.27 | -0.1 | -0.13 |
Tax paid | -0.09 | -0.21 | -0.12 | -0.06 |
Working capital | 0.37 | 2.88 | 0.4 | -7.57 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -44.98 | 31.48 | 43.72 | 14.03 |
Op profit growth | -40.79 | 31.2 | -388.5 | -67.98 |
EBIT growth | -13.81 | -2.85 | 12.77 | 1,144.77 |
Net profit growth | -399.48 | -126.14 | 5.66 | -67.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Jay Kothari
Executive Director
Anju Kothari
Independent Director
Pooja Bhandari
Independent Director
Athak Mahajan
Independent Director
Rajiv Kumar
Company Sec. & Compli. Officer
Arpita Vijayvargiya
01 Panjon Farm House,
Airport Bijasan Road,
Madhya Pradesh - 452005
Tel: -
Website: http://www.panjon.in
Email: bse@panjon.in; info@panjon.in
D-153/A 1st Flr,
Okhla Industrial Are, Phase-I,
New Delhi-110020
Tel: 91-11-26812682
Website: www.skylinerta.com
Email: admin@skylinerta.com/virenr@skylinerta.com
Summary
Incorporated in Dec.83 Panjon Limited became public in 1992. The Company was promoted by Nagin Kothari and Manoj Kothari. The Company is a leading FMCG company. It has marked its presence with signifi...
Read More
Reports by Panjon Ltd
What is the Panjon Ltd share price today?
What is the Market Cap of Panjon Ltd?
What is the PE and PB ratio of Panjon Ltd?
What is the 52 Week High and Low of Panjon Ltd?
What is the CAGR of Panjon Ltd?
What is the shareholding pattern of Panjon Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.